Fecal Incontinence

03/01/2013 - "All patients who underwent intra-anal injection of collagen for passive fecal incontinence with internal sphincter dysfunction between January 2006 and December 2009 were included in the study. "
03/01/2013 - "The aim of this study was to assess the long-term clinical effectiveness of intra-anal injection of collagen for passive fecal incontinence. "
11/01/1999 - "Although collagen weakness was previously implicated in the pathogenesis of incontinence, physical markers in this study could not predict postpartum urinary and fecal incontinence. "
04/01/1995 - "Collagen content was studied in ten patients with neurogenic fecal incontinence (mean age, 51.5 years) and ten controls (age, 58.6 years) using histologic techniques to determine differences between incontinence and health and to determine the effect of aging. "
04/01/1995 - "We aimed to investigate the changes in the proportion of collagen and in the elasticity of the internal anal sphincter in patients with neurogenic fecal incontinence. "

08/01/2015 - "Combination therapy with biofeedback, loperamide, and stool-bulking agents is effective for the treatment of fecal incontinence in women - a randomized controlled trial."
03/15/2012 - "Fecal incontinence is generally treated with loperamide and biofeedback. "
04/01/2009 - "In patients with fecal incontinence: 1) opiates (which reduce colonic motility), 2) loperamide (which has the capacity to dilate the rectum) and 3) anion exchangers which have the capacity to prevent cholonic diarrhea. "
05/01/1987 - "A proportion of children in both groups had a poor postoperative functional outcome as determined by fecal incontinence (2 of 6 in group 1, 6 of 9 in group 2), perianal dermatitis (2 of 6, 4 of 9), and therapy with the antidiarrheal agent loperamide (4 of 6, 2 of 9). "
09/01/1982 - "These results suggest that loperamide may have a specific action on the anal sphincter, which may aid continence in patients who complain of diarrhea and fecal incontinence."

11/01/2014 - "This article reviews both sacral nerve stimulation and dextranomer bulking agents and compares their strengths and potential limitations in patients with fecal incontinence. "
06/01/2009 - "Submucosal injection of stabilized nonanimal hyaluronic acid with dextranomer: a new treatment option for fecal incontinence."
07/16/2014 - "The use of hyaluronic acid and dextranomer (Solesta, Salix) injection in the anal canal is an emerging modality in the treatment of fecal incontinence. "
06/01/2014 - "Two new therapies for fecal incontinence (FI) are now available: non-animal stabilized hyaluronic acid and dextranomer copolymer (NASHA/Dx) and sacral nerve stimulation (SNS). "
06/01/2014 - "Three-year cost-effectiveness model for non-animal stabilized hyaluronic acid and dextranomer copolymer compared with sacral nerve stimulation after conservative therapy for the management of fecal incontinence."

06/01/2009 - "Submucosal injection of stabilized nonanimal hyaluronic acid with dextranomer: a new treatment option for fecal incontinence."
07/16/2014 - "The use of hyaluronic acid and dextranomer (Solesta, Salix) injection in the anal canal is an emerging modality in the treatment of fecal incontinence. "
06/01/2014 - "Two new therapies for fecal incontinence (FI) are now available: non-animal stabilized hyaluronic acid and dextranomer copolymer (NASHA/Dx) and sacral nerve stimulation (SNS). "
06/01/2014 - "Three-year cost-effectiveness model for non-animal stabilized hyaluronic acid and dextranomer copolymer compared with sacral nerve stimulation after conservative therapy for the management of fecal incontinence."
06/01/2011 - "The aim of this prospective study was to analyze safety and functional outcome of transanal submucosal injection of dextranomer hyaluronic acid ("bulking agents therapy") in patients with passive fecal incontinence. "

10/01/2012 - "Local giant cell foreign body reaction after silicone injection for fecal incontinence in humans: two case reports."
10/01/2011 - "[Improvement of fecal incontinence with silicone implants in patients with internal anal sphincter injury: First report in North America]."
04/01/2006 - "The injectable silicone biomaterial is an effective treatment for passive fecal incontinence after hemorrhoidectomy providing good medium-term improvement in fecal incontinence and fecal incontinence-related quality of life."
09/01/2009 - "Evaluation by three-dimensional anal endosonography of injectable silicone biomaterial (PTQ) implants to treat fecal incontinence: long-term localization and relation with the deterioration of the continence."
04/01/2006 - "This case series reviewed the outcome of therapy with injectable silicone biomaterial (PTQ) in patients who had passive fecal incontinence after hemorrhoidectomy. "

08/01/2004 - "The efficacy of increasing doses of oral butyrate (from 50 to 100 mg/kg/day) was investigated through the daily evaluation of stool volume, bowel movements, fecal incontinence, serum, and stool electrolytes concentrations. "
08/01/2006 - "A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence."

08/01/2006 - "In this randomized study, polyethylene glycol and milk of magnesia were equally effective in the long-term treatment of children with constipation and fecal incontinence. "
08/01/2006 - "Seventy-nine children with chronic constipation and fecal incontinence were assigned randomly to receive polyethylene glycol or milk of magnesia and were treated for 12 months in tertiary care pediatric clinics. "
08/01/2006 - "A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence."

08/01/2006 - "In this randomized study, polyethylene glycol and milk of magnesia were equally effective in the long-term treatment of children with constipation and fecal incontinence. "
08/01/2006 - "Seventy-nine children with chronic constipation and fecal incontinence were assigned randomly to receive polyethylene glycol or milk of magnesia and were treated for 12 months in tertiary care pediatric clinics. "
08/01/2006 - "A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence."

12/01/2000 - "Amitriptyline, a tricyclic antidepressant agent with anticholinergic and serotoninergic properties has been used empirically in the treatment of idiopathic fecal incontinence with good results. "
12/01/2000 - "Amitriptyline improved symptoms in 89 percent of patients with fecal incontinence. "
12/01/2000 - "An open study was conducted to test the response to amitriptyline 20 mg daily for four weeks by 18 patients (2 males) of median age 66 years with idiopathic fecal incontinence Incontinence scores, number of bowel movements, computerized ambulatory anorectal pressures, and pudendal nerve terminal motor latencies were evaluated before and after four weeks of therapy. "
12/01/2000 - "Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence."

09/01/2009 - "Given the small number of patients included, we can not yet rule out that topical 10% phenylephrine is useful for the treatment of nocturnal fecal incontinence in patients after ileoanal pouch construction. "
06/10/2015 - "A hollow microneedle (HM) was prepared to deliver a phenylephrine (PE) solution into the anal sphincter muscle as a method for treating fecal incontinence. "
06/10/2015 - "Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence."
09/05/2011 - "We propose pretreatment using microneedles to increase perianal skin permeability for locally targeted delivery of phenylephrine (PE), a drug that increases resting anal sphincter pressure to treat fecal incontinence. "
09/01/2009 - "It has been shown that alpha1-adrenergic agonists as phenylephrine increase anal sphincter pressure in healthy volunteers and in patients with idiopathic fecal incontinence. "

05/01/2001 - "Although most studies report positive results using biofeedback to treat fecal incontinence, quality research is lacking. "
10/01/1994 - "Biofeedback therapy in fecal incontinence has been reported to improve continence in more than 70 percent of patients, but most studies have followed patients for less than two years. "
04/01/1994 - "Doctors have changed their attitudes, and the quality of life of the patient has improved dramatically, thus providing clinical signification, and proof of the validity and applicability of this treatment: using biofeedback without electronic equipment in the treatment of fecal incontinence."
12/01/2000 - "Anorectal biofeedback therapy is a very effective treatment for fecal incontinence. "
01/01/2004 - "This study reported significant short-term improvement in fecal incontinence with electromyographic biofeedback therapy using validated subjective and objective scoring systems. "

06/01/2011 - "The antegrade continence enema (ACE) has been shown to be a safe and effective method for managing fecal incontinence in the pediatric population. "
06/01/2011 - "The Malone appendicostomy, for antegrade enemas, has improved the quality of life for many children with fecal incontinence. "
11/01/2008 - "Despite numerous complications and occasional treatment failures, 90 percent of adult patients with congenital fecal incontinence benefited from antegrade continence enema."
07/01/1998 - "Antegrade continent enema management of chronic fecal incontinence in children."
03/01/1998 - "The objective of this study was to present the use of retrograde colon enema in myelodysplasic patients with fecal incontinence. "

07/01/2012 - "Novel treatment of fecal incontinence with an injectable biocompatible tissue bulking agent."
06/01/2009 - "This study was performed to evaluate NASHA Dx gel as an injectable anal canal implant for the treatment of fecal incontinence. "
08/01/2014 - "Injectable bulking treatment for fecal incontinence (FI) is intended to expand tissue in the anal canal and prevent fecal leakage. "
12/28/2013 - "Newer augmentation treatments such as radiofrequency energy delivery and injectable materials, are minimally invasive tools that may be good options before proceeding to surgery in some patients with mild fecal incontinence. "
11/01/2007 - "Injectable therapy and sacral nerve stimulation are likely to be the mainstay in future treatment of moderate and severe fecal incontinence, respectively. "

08/01/2007 - "Percutaneous cecostomy is a safe and effective procedure for the management of pediatric patients with fecal incontinence. "
04/01/2003 - "The percutaneous cecostomy procedure is a safe and effective method for treating fecal incontinence."
02/01/2015 - "The percutaneous cecostomy procedure provides a safe management option for fecal incontinence in the pediatric population."
02/01/2015 - "Between June 1994 and March 2009, 290 patients (mean age, 10.1 y) with fecal incontinence underwent percutaneous cecostomy tube placement and subsequent tube management. "
02/01/2015 - "The percutaneous cecostomy tube in the management of fecal incontinence in children."

01/01/2015 - "This study is based on the assumption that fecal incontinence among nursing home patients can be prevented, cured or ameliorated by offering care staff knowledge of best practice through a multifaceted educational program. "
01/01/2013 - "This knowledge is important for staff in nursing home in order to provide the best treatment and care for residents with fecal incontinence."
01/01/2001 - "9) Additional research is needed to better define the mechanisms responsible for fecal incontinence, to assess the efficacy of these treatments, to develop better treatments for nursing home residents, and to identify predictors of outcome."
01/01/2015 - "Effect of a multifaceted educational program for care staff concerning fecal incontinence in nursing home patients: study protocol of a cluster randomized controlled trial."
12/01/2010 - "Study participants included 45 elderly (age range: 68 to 103 years) female residents of one nursing home who were incontinent of feces and urine (dual incontinence group--DIG, n = 35) or feces only (fecal incontinence group--FIG, n= 10). "